These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 31051683)

  • 1. Hybrid Capture 2 human papilloma virus testing for head and neck cytology specimens.
    Chute DJ; Aramouni GT; Brainard JA; Hoschar AP; Kroeger A; Yen-Lieberman B
    J Am Soc Cytopathol; 2014; 3(4):173-182. PubMed ID: 31051683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
    Knoepp SM; Kuebler DL; Wilbur DC
    Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens.
    Iftner T; Wang L; Iftner A; Holz B; Haedicke-Jarboui J; Iftner N; von Wasielewski R; Martus P; Boehmer G
    BMC Infect Dis; 2016 Nov; 16(1):672. PubMed ID: 27835974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
    Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
    J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptima HR-HPV testing from Diff-Quick-stained fine-needle aspiration smears of oropharyngeal squamous cell carcinoma.
    Han M; Bernadt CT; Murray B; Johnson SM; Jalaly JB; Garcia T; Adhikari LJ
    J Am Soc Cytopathol; 2016; 5(4):221-226. PubMed ID: 31042512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening.
    Naryshkin S; Austin RM
    Drug Healthc Patient Saf; 2012; 4():167-72. PubMed ID: 23152707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.
    Xu L; Oštrbenk A; Poljak M; Arbyn M
    J Clin Virol; 2018 Jan; 98():37-42. PubMed ID: 29241150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes.
    Lindemann ML; Dominguez MJ; de Antonio JC; Sandri MT; Tricca A; Sideri M; Khiri H; Ravet S; Boyle S; Aldrich C; Halfon P
    J Mol Diagn; 2012 Jan; 14(1):65-70. PubMed ID: 22079749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of p16 immunohistochemistry in FNA biopsies with corresponding tissue specimens in HPV-related squamous cell carcinomas of the oropharynx.
    Jalaly JB; Lewis JS; Collins BT; Wu X; Ma XJ; Luo Y; Bernadt CT
    Cancer Cytopathol; 2015 Dec; 123(12):723-31. PubMed ID: 26242494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and genotype of high-risk human papillomavirus in fine-needle aspirates of patients with metastatic squamous cell carcinoma is helpful in determining tumor origin.
    Baldassarri R; Aronberg R; Levi AW; Yarbrough WG; Kowalski D; Chhieng D
    Am J Clin Pathol; 2015 May; 143(5):694-700. PubMed ID: 25873503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.
    Hauck F; Oliveira-Silva M; Dreyer JH; Perrusi VJ; Arcuri RA; Hassan R; Bonvicino CR; Barros MH; Niedobitek G
    Virchows Arch; 2015 Jun; 466(6):685-93. PubMed ID: 25820374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical biopsy rates before and after the introduction of human papillomavirus type reporting in co-tests with negative cytology.
    Ruff H; Mody D; Luna E; Armylagos D; Thrall MJ
    J Am Soc Cytopathol; 2017; 6(5):180-184. PubMed ID: 31043240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic HPV-related head and neck squamous cell carcinoma to the lung and mediastinal lymph nodes in aspirated cytology material: A diagnostic pitfall.
    Banet N; Rooper LM; Maleki Z
    Diagn Cytopathol; 2016 Mar; 44(3):206-14. PubMed ID: 26764038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing for high-risk HPV in cervical and tonsillar paraffin-embedded tissue using a cartridge-based assay.
    Virtanen E; Laurila P; Hagström J; Nieminen P; Auvinen E
    APMIS; 2017 Oct; 125(10):910-915. PubMed ID: 28736821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of human papillomavirus using hybrid capture 2 in oral brushings from patients with oropharyngeal squamous cell carcinoma.
    Jarboe EA; Willis M; Bentz B; Buchmann L; Hunt J; Ellis G; Layfield L
    Am J Clin Pathol; 2011 May; 135(5):766-9. PubMed ID: 21502432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary.
    Zhang MQ; El-Mofty SK; Dávila RM
    Cancer; 2008 Apr; 114(2):118-23. PubMed ID: 18300234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.
    Begum S; Gillison ML; Nicol TL; Westra WH
    Clin Cancer Res; 2007 Feb; 13(4):1186-91. PubMed ID: 17317828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
    Dong L; Wang MZ; Zhao XL; Feng RM; Hu SY; Zhang Q; Smith JS; Qiao YL; Zhao FH
    Gynecol Oncol; 2018 Jan; 148(1):103-110. PubMed ID: 29169614
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.